Miwon Chemicals Co., Ltd.
KRX:134380.KS
79300 (KRW) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) KRW.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 232,615.76 | 235,165.568 | 197,470.078 | 160,234.351 | 154,724.322 | 146,485.072 | 151,063.207 | 139,901.001 | 145,730.165 | 151,806.783 | 144,246.654 | 121,285.087 | 121,172.921 |
| Cost of Revenue
| 190,676.859 | 199,360.524 | 169,745.007 | 130,425.558 | 127,176.141 | 127,059.904 | 122,098.433 | 110,160.623 | 118,836.208 | 128,048.696 | 118,847.02 | 100,840.741 | 97,926.917 |
| Gross Profit
| 41,938.901 | 35,805.044 | 27,725.071 | 29,808.793 | 27,548.181 | 19,425.168 | 28,964.774 | 29,740.378 | 26,893.956 | 23,758.087 | 25,399.634 | 20,444.346 | 23,246.004 |
| Gross Profit Ratio
| 0.18 | 0.152 | 0.14 | 0.186 | 0.178 | 0.133 | 0.192 | 0.213 | 0.185 | 0.157 | 0.176 | 0.169 | 0.192 |
| Reseach & Development Expenses
| 687.408 | 979.532 | 833.522 | 678.05 | 254.842 | 212.71 | 450.415 | 451.051 | 340.084 | 386.924 | 400.943 | 295.394 | 322.697 |
| General & Administrative Expenses
| 528.656 | 414.09 | 332.088 | 336.442 | 498.93 | 514.104 | 546.271 | 538.711 | 453.358 | 384.8 | 403.59 | 446.691 | 411.607 |
| Selling & Marketing Expenses
| 11,736.485 | 11,469.318 | 10,239.018 | 9,121.547 | 7,807.45 | 7,355.729 | 11,302.438 | 9,275.614 | 9,508.627 | 9,382.655 | 8,918.607 | 8,635.907 | 8,199.864 |
| SG&A
| 16,293.719 | 11,883.408 | 10,571.106 | 9,457.988 | 8,306.38 | 7,869.833 | 11,848.709 | 9,814.325 | 9,961.985 | 9,767.455 | 9,322.198 | 9,082.598 | 8,611.471 |
| Other Expenses
| -44.38 | 3,958.904 | 3,548.335 | 3,520.278 | 3,502.806 | 202.838 | 32.77 | 346.823 | 310.645 | 270.856 | 370.187 | 270.62 | 166.126 |
| Operating Expenses
| 17,025.507 | 16,821.844 | 14,952.963 | 13,656.316 | 12,064.028 | 10,780.36 | 15,399.749 | 13,714.455 | 13,219.944 | 12,987.821 | 12,283.773 | 11,579.402 | 11,373.195 |
| Operating Income
| 24,913.394 | 18,983.2 | 12,772.108 | 16,152.477 | 15,484.153 | 8,644.808 | 13,565.024 | 16,025.923 | 13,674.012 | 10,770.266 | 13,115.861 | 8,864.944 | 12,009.88 |
| Operating Income Ratio
| 0.107 | 0.081 | 0.065 | 0.101 | 0.1 | 0.059 | 0.09 | 0.115 | 0.094 | 0.071 | 0.091 | 0.073 | 0.099 |
| Total Other Income Expenses Net
| 1,850.344 | 1,955.522 | 1,790.741 | -223.121 | 926.372 | 544.676 | 3,557.667 | 1,319.83 | 883.062 | 593.089 | -176.14 | 1,003.967 | -458.26 |
| Income Before Tax
| 26,842.53 | 20,938.723 | 14,562.85 | 15,929.356 | 16,410.524 | 9,545.215 | 17,122.692 | 17,609.675 | 14,769.604 | 11,363.355 | 13,139.528 | 9,868.911 | 11,551.62 |
| Income Before Tax Ratio
| 0.115 | 0.089 | 0.074 | 0.099 | 0.106 | 0.065 | 0.113 | 0.126 | 0.101 | 0.075 | 0.091 | 0.081 | 0.095 |
| Income Tax Expense
| 5,168.907 | 4,678.207 | 3,212.662 | 2,152.299 | 2,903.904 | 2,174.743 | 3,543.495 | 3,874.986 | 3,005.296 | 2,436.337 | 2,649.299 | 2,118.071 | 1,848.679 |
| Net Income
| 21,814.09 | 16,260.515 | 11,350.187 | 13,777.057 | 13,506.621 | 7,370.473 | 13,579.197 | 13,734.689 | 11,764.307 | 8,927.018 | 10,490.23 | 7,750.84 | 9,702.941 |
| Net Income Ratio
| 0.094 | 0.069 | 0.057 | 0.086 | 0.087 | 0.05 | 0.09 | 0.098 | 0.081 | 0.059 | 0.073 | 0.064 | 0.08 |
| EPS
| 10,762 | 7,958.75 | 5,570.53 | 6,805.87 | 6,718.66 | 3,675.19 | 6,265 | 6,008 | 5,017 | 3,826 | 4,526 | 3,364 | 4,236 |
| EPS Diluted
| 10,749 | 7,958.75 | 5,570.53 | 6,805.87 | 6,718.66 | 3,675.19 | 6,265 | 6,008 | 5,017 | 3,826 | 4,526 | 3,364 | 4,236 |
| EBITDA
| 40,264.411 | 32,590.59 | 26,245.957 | 25,973.705 | 22,712.698 | 15,087.724 | 21,907.823 | 22,452.442 | 17,769.709 | 14,704.206 | 17,058.561 | 13,754.519 | 13,517.141 |
| EBITDA Ratio
| 0.165 | 0.138 | 0.132 | 0.162 | 0.147 | 0.098 | 0.093 | 0.145 | 0.122 | 0.101 | 0.12 | 0.105 | 0.11 |